• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy.

作者信息

Shibata S, Tada Y, Hau C, Tatsuta A, Yamamoto M, Kamata M, Karakawa M, Asano Y, Mitsui H, Sugaya M, Kadono T, Saeki H, Kanda N, Sato S

出版信息

Br J Dermatol. 2011 Mar;164(3):667-70. doi: 10.1111/j.1365-2133.2010.10123.x. Epub 2011 Feb 3.

DOI:10.1111/j.1365-2133.2010.10123.x
PMID:21062267
Abstract
摘要

相似文献

1
Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy.脂联素作为银屑病发病机制中的一种抗炎因子：治疗后血清脂联素水平升高的诱导作用。
Br J Dermatol. 2011 Mar;164(3):667-70. doi: 10.1111/j.1365-2133.2010.10123.x. Epub 2011 Feb 3.
2
Serum high molecular weight adiponectin levels are decreased in psoriasis patients.银屑病患者血清高分子量脂联素水平降低。
J Dermatol Sci. 2009 Jul;55(1):62-3. doi: 10.1016/j.jdermsci.2009.02.009. Epub 2009 Apr 22.
3
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.阿达木单抗治疗重度银屑病和银屑病关节炎：一项针对30例曾接受其他生物制剂治疗患者的开放标签研究。
J Am Acad Dermatol. 2007 Aug;57(2):269-75. doi: 10.1016/j.jaad.2006.12.003. Epub 2007 Jun 18.
4
Serum level of adiponectin increases and those of leptin and resistin decrease following the treatment of psoriasis.银屑病治疗后，血清脂联素水平升高，而瘦素和抵抗素水平降低。
J Dermatol. 2013 Jun;40(6):475-6. doi: 10.1111/1346-8138.12122. Epub 2013 Mar 12.
5
Ustekinumab for psoriasis and psoriatic arthritis.优特克单抗用于治疗银屑病和银屑病关节炎。
J Rheumatol Suppl. 2012 Jul;89:86-9. doi: 10.3899/jrheum.120253.
6
Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis.
Australas J Dermatol. 2008 Aug;49(3):173-4. doi: 10.1111/j.1440-0960.2008.00458.x.
7
Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.采用Goeckerman疗法治疗的银屑病患者血清中促炎细胞因子白细胞介素-12和抗炎细胞因子白细胞介素-10的水平。
Int J Dermatol. 2008 Aug;47(8):800-5. doi: 10.1111/j.1365-4632.2008.03677.x.
8
Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.阿达木单抗成功治疗重度银屑病和银屑病关节炎。
Br J Dermatol. 2004 Aug;151(2):492-6. doi: 10.1111/j.1365-2133.2004.06105.x.
9
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.依那西普对银屑病及银屑病关节炎患者C反应蛋白水平的影响。
Br J Dermatol. 2008 Aug;159(2):322-30. doi: 10.1111/j.1365-2133.2008.08628.x. Epub 2008 May 22.
10
Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver.阿达木单抗治疗一名肝硬化患者的银屑病和银屑病关节炎。
J Am Acad Dermatol. 2008 Nov;59(5 Suppl):S117-8. doi: 10.1016/j.jaad.2008.06.019.

引用本文的文献

1
Is adiponectin involved in morphea pathogenesis? - first observational study.脂联素是否参与硬斑病的发病机制？——首次观察性研究。
Front Immunol. 2025 May 30;16:1588439. doi: 10.3389/fimmu.2025.1588439. eCollection 2025.
2
Serum Adiponectin Levels as an Independent Marker of Severity of Psoriasis: A Cross-Sectional Analysis.血清脂联素水平作为银屑病严重程度的独立标志物：一项横断面分析。
J Psoriasis Psoriatic Arthritis. 2023 Oct;8(4):148-155. doi: 10.1177/24755303231199995. Epub 2023 Aug 31.
3
The Link Between Weight-Adjusted-Waist Index and Psoriasis in Adults: A Cross-Sectional Study Based on 2009-2014 and 2003-2006 Data.
成人体重调整腰围指数与银屑病之间的关联：一项基于2009 - 2014年和2003 - 2006年数据的横断面研究
Clin Cosmet Investig Dermatol. 2024 Aug 5;17:1763-1772. doi: 10.2147/CCID.S471528. eCollection 2024.
4
The Intersection of the Pathogenic Processes Underlying Psoriasis and the Comorbid Condition of Obesity.银屑病潜在致病过程与肥胖合并症的交集
Life (Basel). 2024 Jun 7;14(6):733. doi: 10.3390/life14060733.
5
Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression.血常规衍生的炎症标志物在银屑病疾病进展中的影响
Life (Basel). 2024 Jan 12;14(1):114. doi: 10.3390/life14010114.
6
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.深入了解化脓性汗腺炎的分子发病机制和免疫调节治疗。
Int J Mol Sci. 2023 May 8;24(9):8428. doi: 10.3390/ijms24098428.
7
Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis.治疗前全身炎症标志物对生物制剂和传统全身治疗持续治疗的影响：一项寻常型银屑病和银屑病关节炎患者的回顾性研究
J Clin Med. 2023 Apr 21;12(8):3046. doi: 10.3390/jcm12083046.
8
The Role of Adipokines in the Pathogenesis of Psoriasis.脂肪细胞因子在银屑病发病机制中的作用。
Int J Mol Sci. 2023 Mar 28;24(7):6390. doi: 10.3390/ijms24076390.
9
Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity.脂肪组织在肥胖相关性银屑病和特应性皮炎发病机制中的新作用
JID Innov. 2021 Oct 13;2(1):100064. doi: 10.1016/j.xjidi.2021.100064. eCollection 2022 Jan.
10
Adiponectin in psoriasis and its comorbidities: a review.银屑病及其合并症中的脂联素：综述。
Lipids Health Dis. 2021 Aug 9;20(1):87. doi: 10.1186/s12944-021-01510-z.